These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26324800)

  • 1. Coagulation and anticoagulation in idiopathic pulmonary fibrosis.
    Crooks MG; Hart SP
    Eur Respir Rev; 2015 Sep; 24(137):392-9. PubMed ID: 26324800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.
    Kreuter M; Wijsenbeek MS; Vasakova M; Spagnolo P; Kolb M; Costabel U; Weycker D; Kirchgaessler KU; Maher TM
    Eur Respir J; 2016 Jun; 47(6):1776-84. PubMed ID: 27103382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis.
    Lin C; Borensztajn K; Spek CA
    J Thromb Haemost; 2017 Apr; 15(4):597-607. PubMed ID: 28079978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic system related to pulmonary arterial pressure and lung function of patients with idiopathic pulmonary fibrosis.
    Ban C; Wang T; Zhang S; Xin P; Liang L; Wang C; Dai H
    Clin Respir J; 2017 Sep; 11(5):640-647. PubMed ID: 26425916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.
    Moodley Y; Corte T; Richeldi L; King TE
    Respirology; 2015 Apr; 20(3):389-94. PubMed ID: 25727967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
    Hyldgaard C; Hilberg O; Bendstrup E
    Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study.
    Navaratnam V; Fogarty AW; McKeever T; Thompson N; Jenkins G; Johnson SR; Dolan G; Kumaran M; Pointon K; Hubbard RB
    Thorax; 2014 Mar; 69(3):207-15. PubMed ID: 24002055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?
    Mahendran S; Sethi T
    QJM; 2012 Oct; 105(10):929-34. PubMed ID: 22647761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
    Ryerson CJ; Cottin V; Brown KK; Collard HR
    Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
    Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
    Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
    BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
    Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
    Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis.
    O'Dwyer DN; Ashley SL; Gurczynski SJ; Xia M; Wilke C; Falkowski NR; Norman KC; Arnold KB; Huffnagle GB; Salisbury ML; Han MK; Flaherty KR; White ES; Martinez FJ; Erb-Downward JR; Murray S; Moore BB; Dickson RP
    Am J Respir Crit Care Med; 2019 May; 199(9):1127-1138. PubMed ID: 30789747
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
    Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
    Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis.
    Cameli P; Bergantini L; Salvini M; Refini RM; Pieroni M; Bargagli E; Sestini P
    Nitric Oxide; 2019 Aug; 89():41-45. PubMed ID: 31054949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
    Noth I; Anstrom KJ; Calvert SB; de Andrade J; Flaherty KR; Glazer C; Kaner RJ; Olman MA;
    Am J Respir Crit Care Med; 2012 Jul; 186(1):88-95. PubMed ID: 22561965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
    Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
    Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.